Determination of imatinib mesylate and erlotinib hydrochloride in mice plasma using ultrahigh performance liquid chromatography method by Gülen Melike Demir, İsmail Tuncer Degim

Subjects: “…Erlotinib…”
Get full text

Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation by Yujing Wang, Wenjie Huang, Haidong Jia, Qinglian Tang, Qingfei Yin, Yuanyuan Chen, Wumei Wang, Zhengyu Cao

Subjects: Get full text

Botriomicosis asociada a tratamiento con erlotinib en una paciente con adenocarcinoma de pulmón by Claudia Montoya, Francisco López

Subjects: “…Botriomicosis, erlotinib, adenocarcinoma de pulmón.…”
Get full text

Upregulated interleukin‐6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma by Aditya Stanam, Laurie Love-Homan, Tisha S. Joseph, Madelyn Espinosa-Cotton, Andrean L. Simons

Subjects: Get full text

Bullous fixed drug eruption due to erlotinib: A rare case report by Kallolinee Samal, Manoj Kumar Nayak, Srigopal Mohanty, Nibedita Dixit

Subjects: Get full text

Design, synthesis and anti-cancer activity of novel 1,2,3-triazole hybrids of erlotinib against cervical cancer via MAPK signaling pathway by Lan Wang, Xixi Hou, Mengmeng Huang, Baoyu He, Longfei Mao, Zhengwei Hu, Ling Li, Jingjing Guo, Lizeng Peng

Subjects: Get full text

Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study by Masaki Kanazu, Masahide Mori, Madoka Kimura, Kazumi Nishino, Takayuki Shiroyama, Izumi Nagatomo, Shoichi Ihara, Kiyoshi Komuta, Hidekazu Suzuki, Tomonori Hirashima, Toru Kumagai, Fumio Imamura

Subjects: Get full text

Erlotinib therapy for Olmsted syndrome with p.L655P missense mutation in the TRPV3 gene: a case report by Jia Zhang, MengYue Guo, DongYang Yuan, JinYang Wei, Hongzhou Cui, Hongzhou Cui

Subjects: Get full text

Synergistic activity of Pitstop-2 and 1,6-hexanediol in aggressive human lung cancer cells by Sílvio Terra Stefanello, Caren Rigon Mizdal, Aline Franzen da Silva, Luca Matteo Todesca, Félix Alexandre Antunes Soares, Victor Shahin

Subjects: Get full text

OPTIMAL SEQUENCE OF APPLICATION OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVATING EGFR MUTATIONS by A. A. Kolomeytseva, A. A. Fedenko

Subjects: Get full text

Bufadienolides from Chansu Injection Synergistically Enhances the Antitumor Effect of Erlotinib by Inhibiting the KRAS Pathway in Pancreatic Cancer by Yanli Guo, Yu Jin, Jie Gao, Ding Wang, Yanming Wang, Liya Shan, Mengyu Yang, Xinzhi Li, Ketao Ma

Subjects: Get full text

Unusual Cutaneous Reaction with Erlotinib: A Brief Report with Current Review of Management of Tyrosine Kinase Inhibitor-associated Cutaneous Toxicity by Aashita, Vikas Yadav, Pragyat Thakur, Anuja Kapoor

Subjects: Get full text

Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures by Ana Podolski-Renić, Sofija Jovanović Stojanov, Dragana Marić, Jelena Dinić, Miodrag Dragoj, Ana Stepanović, Ema Lupšić, Milica Pajović, Sofija Glumac, Maja Ercegovac, Milica Pešić

Subjects: Get full text

PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL L... by A. U. Kulikov

Subjects: Get full text

Prognostic significance of calcium-related genes in lung adenocarcinoma and the role of TNNC1 in macrophage polarization and erlotinib resistance by Jian Feng, Zhe Chen, Gaoming Wang, Yu Yao, Xuewen Min, Jing Luo, Kai Xie

Subjects: Get full text

Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Ad... by Yan-Jei Tang, John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Chiao-En Wu

Subjects: Get full text

Physicochemical characterization and biological evaluation of amorphous solid dispersions of an anticancerous drug: Erlotinib HCl by K. P. Safna Hussan, Thekkekara D. Babu, M. Shahin Thayyil, T. S. Sreeshma, A. Archana

Subjects: “…Erlotinib-HCl (ERL)…”
Get full text

Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review by Chen Y, Yang S, Liu Y, Liu H, Luo Y

Subjects: Get full text